Fujiwara Tohru
Department of Laboratory Medicine and Infectious Diseases, Iwate Medical University School of Medicine.
Rinsho Ketsueki. 2024;65(9):911-919. doi: 10.11406/rinketsu.65.911.
Sideroblastic anemias (SAs) are a diverse group of congenital and acquired disorders, characterized by anemia and the presence of ring sideroblasts in bone marrow. Congenital SA is a rare disorder that results from genetic mutations that impair heme biosynthesis, iron-sulfur [Fe-S] cluster biosynthesis, and mitochondrial protein synthesis. The predominant type of congenital SA is X-linked sideroblastic anemia, caused by mutations in the erythroid-specific δ-aminolevulinate synthase (ALAS2) gene, a key enzyme in the heme biosynthesis pathway in erythroid cells. SAs can also arise due to exposure to certain drugs or alcohol or to copper deficiency (secondary SAs). They are also often associated with myelodysplastic syndrome (idiopathic SA), and idiopathic SAs are the most frequently encountered type. This review discusses the current understanding of the pathophysiology underlying SA.
铁粒幼细胞性贫血(SA)是一组多样的先天性和后天性疾病,其特征为贫血以及骨髓中出现环形铁粒幼细胞。先天性SA是一种罕见疾病,由损害血红素生物合成、铁硫[Fe-S]簇生物合成和线粒体蛋白质合成的基因突变引起。先天性SA的主要类型是X连锁铁粒幼细胞性贫血,由红系特异性δ-氨基乙酰丙酸合成酶(ALAS2)基因突变所致,该酶是红系细胞血红素生物合成途径中的关键酶。SA也可因接触某些药物或酒精或因铜缺乏(继发性SA)而发生。它们还常与骨髓增生异常综合征相关(特发性SA),且特发性SA是最常见的类型。本综述讨论了目前对SA潜在病理生理学的理解。